Abstract
Most cases of Alzheimer’s disease (AD) are sporadic in nature, although rarer familial AD (FAD) cases have provided important insights into major pathological disease mechanisms. Mutations in the presenilin 1 gene (PS1) are responsible for the majority of FAD cases, causing an earlier age of onset and more rapid progression to end-stage disease than seen in sporadic AD. We have investigated the cytoskeletal alterations in neuritic AD pathology in a cohort of FAD cases in comparison to sporadic AD and pathologically aged cases. Tau-immunoreactive neurofibrillary tangle (NFT) loads were similar between PS1 FAD and sporadic AD cases. Similarly, plaque loads, both β-amyloid (Aβ) and thioflavine S, in PS1 FAD and sporadic AD cases were not significantly different; however, in pathologically aged cases, they were significantly lower than those in PS1 cases, but were not different from sporadic AD cases. The ‘cotton wool’ plaque characteristic of PS1 cases did not demonstrate a high density of dystrophic neurites compared to other Aβ plaque types, but did demonstrate a localised mass effect on the neuropil. Despite minimal differences in plaque and NFT loads, immunolabelling demonstrated clear phenotypic differences in the NFTs and dystrophic neurites in PS1 FAD cases. Presenilin-1 cases exhibited significantly (P < 0.05) more tau-positive NFTs that were immunolabelled by the antibody SMI312 (anti-phosphorylated NF protein and phosphorylated tau) than sporadic AD cases. Presenilin-1 cases also exhibited numerous ring-like NF-positive and elongated tau-labelled dystrophic neurites, whereas these dystrophic neurite types were only abundant at the very early (pathologically aged cases) or very late stages of sporadic AD progression, respectively. These differences in cytoskeletal pathology in PS1 cases suggest an accelerated rate of neuritic pathology development, potentially due to mutant PS1 influencing multiple pathogenic pathways.
Similar content being viewed by others
References
Akiyama H, Schwab C, Kondo H et al (2002) Morphologically distinct plaque types differentially affect dendritic structure and organization in the early and late stages of Alzheimer’s disease. Acta Neuropathol 103:377–383
Armstrong RA (1998) β-Amyloid plaques: stages in life history or independent origin? Dement Geriatr Cogn Disord 9:227–238
Biernat J, Wu Y-Z, Timm T et al (2002) Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity. Mol Biol Cell 13:4013–4028
Blanchard V, Moussaoui S, Czech C et al (2003) Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice. Exp Neurol 184:247–263
Borchelt DR, Thinakaran G, Eckman CB et al (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17:1005–1013
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259
Busciglio J, Lorenzo A, Yeh J, Yanker BA (1995) β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879–888
Campion D, Dumanchin C, Hannequin D et al (1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65:664–670
Chen Q, Nakajima A, Choi SH, Xiong X, Tang YP (2008) Loss of presenilin function causes Alzheimer’s disease-like neurodegeneration in the mouse. J Neurosci Res 86:1615–1626
Crook R, Verkkoniemi A, Perez-Tur J et al (1998) A variant of Alzheimer’s disease with spastic paraparesis and unusual plaques due to the deletion of exon 9 of presenilin 1. Nat Med 4:452–455
Czech C, Tremp G, Pradier L (2000) Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms. Prog Neurobiol 60:363–384
De Felice FG, Wu D, Lambert MP et al (2008) Alzheimer’s disease-type neuronal tau hyperphosphorylation induced by Abeta oligomers. Neurobiol Aging 29:1334–1347
Dickson TC, Chuckowree JA, Chuah MI, West AK, Vickers JC (2005) Novel Alzheimer’s disease pathology reflects variable neuronal vulnerability and demonstrates the role of β-amyloid plaques in neurodegeneration. Neurobiol Dis 18:286–295
Dickson TC, Vickers JC (2001) The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer’s disease. Neuroscience 105:99–107
Dickson TC, King CE, McCormack GH, Vickers JC (1999) Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer’s disease. Exp Neurol 156:100–110
Dowjat WK, Wisniewski H, Wisniewski T (2001) Alzheimer’s disease presenilin-1 expression modulates the assembly of neurofilaments. Neuroscience 103:1–8
Evans J, Sumners C, Moore J et al (2002) Characterisation of mitotic neurons derived from adult rat hypothalamus and brain stem. J Neurophysiol 87:1076–1085
Ferreira A, Lu Q, Orecchio L, Kosik KS (1997) Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar Abeta. Mol Cell Neurosci 9:220–234
Fukumoto H, Asami-Odaka AS, Uzuki N, Iwatsubo T (1996) Association of Aβ40-positive senile plaques with microglial cells in the brains of patients with Alzheimer’s disease and in non-demented aged individuals. Neurodegeneration 5:13–17
Giannakopoulos P, Herrmann FR, Bussiere T et al (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology 60:1495–1500
Gomez-Isla T, Growdon WB, McNamara MJ et al (1999) The impact of different presenilin 1 and presenilin 2 mutation on amyloid deposition neurofibrillary changes and neuronal loss in familial Alzheimer’s disease brain: evidence for other phenotype-modifying factors. Brain 122:1709–1719
Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (1998) Genetic dissection of Alzheimer’s disease and related dementias: amyloid and its relationship to tau. Nat Neurosci 1:355–358
Houlden H, Baker M, McGowan E et al (2000) Variant Alzheimer’s disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrations. Ann Neurol 48:806–808
Ishihara T, Higuchi M, Zhang B et al (2001) Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments. J Neurosci 21:6026–6035
Ishii K, Ii K, Hasegawa T, Shoji S, Doi A, Mori H (1997) Increased Abeta 42(43)-plaque deposition in early-onset familial Alzheimer’s disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene. Neurosci Lett 228:17–20
Karlstrom H, Brooks WS, Kwok JBJ et al (2008) Variable phenotype of Alzheimer’s disease with spastic paraparesis. J Neurochem 104:573–583
Kwok JBJ, Halliday GM, Brooks WS et al (2003) Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer’s disease with non-cored plaques and no neuritic dystrophy. J Biol Chem 278:6748–6754
Lazarov O, Morfini GA, Pigino G et al (2007) Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer’s Disease-linked mutant presenilin 1. J Neurosci 27:7011–7020
Lippa CF, Saunders AM, Smith TW et al (1996) Familial and sporadic Alzheimer’s disease: neuropathology cannot exclude a final common pathway. Neurology 46:406–412
Mann DMA, Pickering-Brown SM, Takeuchi A, Iwatsubo T, Familial Alzheimer’s disease pathology study group (2001) Amyloid angiopathy and variability in amyloid-β deposition is determined by mutation position in presenilin-1-linked Alzheimer’s disease. Am J Pathol 158:2165–2175
Mann DMA, Takeuchi A, Sato S et al (2001) Cases of Alzheimer’s disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic β-amyloid pathology known as ‘cotton wool’ plaques. Neuropathol Appl Neurobiol 27:189–196
Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R (1993) An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer’s disease. Am J Pathol 142:871–881
Masliah E, Sisk A, Mallory M, Games D (2001) Neurofibrillary pathology in transgenic mice overexpressing V717F β-Amyloid precursor protein. J Neuropathol Exp Neurol 60:357–368
Meyer-Luehmann M, Spires-Jones TL, Prada C et al (2008) Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease. Nature 451:720–724
Mirra SS, Heyman A, McKeel D et al (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer’s disease. Neurology 41:479–486
Pérez M, Asunción Morán M, Ferrer I et al (2008) Phosphorylated tau in neuritic plaques of APPsw/Tauvlw transgenic mice and Alzheimer disease. Acta Neuropathol 116:409–418
Pigino G, Pelsman A, Mori H, Busciglio J (2001) Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J Neurosci 21:834–842
Porzig R, Singer D, Hoffmann R (2007) Epitope mapping of mABs AT8 and Tau5 directed against hyperphosphoylated regions of the human tau protein. Biochem Biophys Res Commun 358:644–649
Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 45:358–368
Savage MJ, Iqbal M, Loh T et al (1994) Cathespin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience 60:607–619
Scheuner D, Eckman C, Jensen M et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2:850–852
Schmidt M, Lee VM, Trojanowski JQ (1989) Analysis of epitopes shared by Hirano bodies and neurofilament proteins in normal and Alzheimer’s disease hippocampus. Lab Invest 60:513–522
Selkoe DJ (1996) (1996) Amyloid beta-protein and the genetics of Alzheimer’s disease. J Biol Chem 271:18295–18298
Shepherd CE, Gregory GC, Vickers JC et al (2004) Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques. Neurobiol Dis 15:115–119
Stanford PM, Shepherd CE, Halliday GM et al (2003) Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 126:814–826
Steiner H, Revesz T, Neumann M et al (2001) A pathogenic presenilin-1 deletion causes aberrant Aβ42 production in the absence of congophilic amyloid plaques. J Biol Chem 276:7233–7239
Su JH, Cummings BJ, Cotman CW (1996) Plaque biogenesis in brain aging and Alzheimer’s disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res 739:79–87
Su JH, Cummings BJ, Cotman CW (1998) Plaque biogenesis in brain aging and Alzheimer’s disease. II. Progressive transformation and developmental sequence of dystrophic neurites. Acta Neuropathol 96:463–471
Takao M, Ghetti B, Hayakawa I et al (2002) A novel mutation (G217D) in the presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and Parkinsonism are associated with cotton wool plaques in the cortex and striatum. Acta Neuropathol 104:155–170
Takashima A, Murayama M, Murayama O et al (1998) Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau. Proc Natl Acad Sci USA 95:9637–9641
Vickers JC, Dickson TC, Adlard PA, Saunders HL, King CE, McCormack G (2000) The cause of neuronal degeneration in Alzheimer’s disease. Prog Neurobiol 60:139–165
Vickers JC, Riederer BM, Marugg R, Buée-Scherrer V, Buée L, Delacourtes A (1994) Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer’s disease. Neuroscience 62:1–13
Woodhouse A, West AK, Chuckowree JA, Vickers JC, Dickson TC (2005) Does β-amyloid plaque formation cause structural injury to neuronal processes? Neurotox Res 7:5–15
Woodhouse A, Vickers JC, Adlard PA, Dickson TC (2007) Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging. Neurobiol Aging (in press). 18 October 2007 [Epub ahead of print]
Acknowledgments
Tissues were received from the Australian Brain Donor Programs Prince of Wales Medical Research Institute Tissue Resource Centre and South Australian Brain Bank, and from the Sun Health Research Institute in Arizona, USA. We wish to thank the study participants and their families who have given considerable time and eventually brain tissue to this research program, to those who participated in clinically evaluating study participants and to the staff of the neuropathology laboratory at POWMRI for tissue processing. Thanks also to Michelle Hill for her assistance with the Western Blots. This research was supported by the University of New South Wales, Gold Star Award, the Tasmanian Masonic Centenary Medical Research Foundation, National Health and Medical Research Council and the J.O. and J.R. Wicking Charitable Trust (ANZ Charitable Services). The Australian Brain Donor Programs Prince of Wales Medical Research Institute Tissue Resource Centre and South Australian Brain Bank are supported by the National Health and Medical Research Council of Australia. G.M.H. is a Principal Research Fellow and T.C.D. a Career Development Fellow of the National Health and Medical Research Council of Australia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Woodhouse, A., Shepherd, C.E., Sokolova, A. et al. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer’s disease. Acta Neuropathol 117, 19–29 (2009). https://doi.org/10.1007/s00401-008-0458-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-008-0458-z